C. BOZ Et Al. , "Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up," 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS , vol.25, Stockholm, Sweden, pp.870, 2019
BOZ, C. Et Al. 2019. Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up. 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS , (Stockholm, Sweden), 870.
BOZ, C., TERZİ, M., ÖZAKBAŞ, S., YÜCEYAR, A. N., EFENDİ, H., PETEK BALCI, B., ... Türkoğlu, R.(2019). Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up . 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS (pp.870). Stockholm, Sweden
BOZ, CAVİT Et Al. "Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up," 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 2019
BOZ, CAVİT Et Al. "Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up." 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS , Stockholm, Sweden, pp.870, 2019
BOZ, C. Et Al. (2019) . "Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up." 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS , Stockholm, Sweden, p.870.
@conferencepaper{conferencepaper, author={CAVİT BOZ Et Al. }, title={Real world efficacy and safety of teriflunomide in multiple sclerosis: an observational study with four years follow-up}, congress name={35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS}, city={Stockholm}, country={Sweden}, year={2019}, pages={870} }